Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Konkret geht es um den Diabetes-Patienten mit kardiovaskulären Erkrankungen oder Risiken, die Herzinsuffizienz sowie die kardiovaskuläre Primär- und Sekundärprävention. Sind Sie hier schon auf dem neuesten Stand? Unsere Experten beleuchten, wo und warum das bisherige Procedere geändert werden soll und was in der Praxis sinnvoll ist. Holen Sie sich Ihr Update und 2 CME-Punkte beim MMW-Webinar am 24. April von 17.30 bis 19 Uhr. 
Erweiterte Suche
Anmelden
nach oben
Herzschrittmachertherapie + Elektrophysiologie
Erschienen in: Herzschrittmachertherapie + Elektrophysiologie 4/2016

21.11.2016 | Schwerpunkt

Current rare indications and future directions for implantable loop recorders

verfasst von: Simon Wechselberger, PD Dr. med. habil. Christopher Piorkowski, Dr. med. Matthias Pohl

Erschienen in: Herzschrittmachertherapie + Elektrophysiologie | Ausgabe 4/2016

Einloggen, um Zugang zu erhalten

Abstract

The scope of application for implantable loop recorders has shifted away from the evaluation of unclear palpitations and syncope episodes to more complex conditions. This article focuses on rare indications of growing importance such as rhythm monitoring after ablation of atrial fibrillation or after cryptogenic stroke. Furthermore, forthcoming applications in various clinical settings are described, e. g., arrhythmia detection after myocardial infarction, after catheter-based valve interventions, in heart failure, and in cardiomyopathies. Enhancement of the capabilities of implantable loop recorders could broaden their fields of use.
Literatur
1.
Krahn AD, Klein GJ, Yee R, Takle-Newhouse T, Norris C, the Reveal Investigators (1999) Use of an extended monitoring strategy in patients with problematic syncope. Circulation 99:406–410CrossRefPubMed
2.
Krahn AD, Klein GJ, Yee R, Skanes AC (2001) Randomized assessment of syncope trial: conventional diagnostic testing versus a prolonged monitoring strategy. Circulation 104:46–51CrossRefPubMed
3.
Krahn AD, Klein GJ, Yee R, Hoch JS, Skanes AC (2003) Cost implications of testing strategy in patients with syncope: randomized assessment of syncope trial. J Am Coll Cardiol 42:495–501CrossRefPubMed
4.
Giada F, Gulizia M, Francese M, Croci F, Santangelo L, Santomauro M, Occetta E, Menozzi C, Raviele A (2007) Recurrent unexplained palpitations (RUP) study comparison of implantable loop recorder versus conventional diagnostic strategy. J Am Coll Cardiol 49:1951–1956CrossRefPubMed
5.
Brignole M, Vardas P, Hoffman E, Huikuri H, Moya A, Ricci R, Sulke N, Wieling W, Auricchio A, Lip GY, Almendral J, Kirchhof P, Aliot E, Gasparini M, Braunschweig F, Botto GL (2009) Indications for the use of diagnostic implantable and external ECG loop recorders. Europace 11:671–687CrossRefPubMed
6.
Kanjwal K, Figueredo VM, Karabin B, Grubb BP (2011) The implantable loop recorder: current uses, future directions. J Innov Cardiac Rhythm Manag 2:215–222
7.
Furukawa T, Maggi R, Bertolone C, Fontana D, Brignole M (2012) Additional diagnostic value of very prolonged observation by implantable loop recorder in patients with unexplained syncope. J Cardiovasc Electrophysiol 23:67–71CrossRefPubMed
8.
Pürerfellner H, Sanders P, Pokushalov E, Di Bacco M, Bergemann T, Dekker LR, Reveal LINQ, Reveal LINQ Usability Study Investigators (2015) Miniaturized Reveal LINQ insertable cardiac monitoring system: first-in-human experience. Heart Rhythm 12:1113–1119CrossRefPubMed
9.
Tomson TT, Passman R (2015) The Reveal LINQ insertable cardiac monitor. Expert Rev Med Devices 12:7–18CrossRefPubMed
10.
Calkins H, Kuck KH, Cappato R, Brugada J, Camm AJ, Chen SA, Crijns HJ, Damiano RJ Jr, Davies DW, DiMarco J, Edgerton J, Ellenbogen K, Ezekowitz MD, Haines DE, Haissaguerre M, Hindricks G, Iesaka Y, Jackman W, Jalife J, Jais P, Kalman J, Keane D, Kim YH, Kirchhof P, Klein G, Kottkamp H, Kumagai K, Lindsay BD, Mansour M, Marchlinski FE, McCarthy PM, Mont JL, Morady F, Nademanee K, Nakagawa H, Natale A, Nattel S, Packer DL, Pappone C, Prystowsky E, Raviele A, Reddy V, Ruskin JN, Shemin RJ, Tsao HM, Wilber D (2012) 2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design. Europace 14:528–606CrossRefPubMed
11.
12.
Ajijola OA, Boyle NG, Shivkumar K (2015) Detecting and monitoring arrhythmia recurrence following catheter ablation of atrial fibrillation. Front Physiol 6:90CrossRefPubMedPubMedCentral
13.
Hanke T, Charitos EI, Stierle U, Karluss A, Kraatz E, Graf B, Hagemann A, Misfeld M, Sievers HH (2009) Twenty-four-hour Holter monitor follow-up does not provide accurate heart rhythm status after surgical atrial fibrillation ablation therapy: Up to 12 months experience with a novel permanently implantable heart rhythm monitor device. Circulation 120:S177–S184CrossRefPubMed
14.
Mittal S, Pokushalov E, Romanov A, Ferrara M, Arshad A, Musat D, Preminger M, Sichrovsky T, Steinberg JS (2013) Long-term ECG monitoring using an implantable loop recorder for the detection of atrial fibrillation after cavotricuspid isthmus ablation in patients with atrial flutter. Heart Rhythm 10:1598–1604CrossRefPubMed
15.
Pokushalov E, Romanov A, Corbucci G, Artyomenko S, Turov A, Shirokova N, Karaskov A (2011) Ablation of paroxysmal and persistent atrial fibrillation: 1‑Year follow-up through continuous subcutaneous monitoring. J Cardiovasc Electrophysiol 22:369–375CrossRefPubMed
16.
Gersak B, Pernat A, Robic B, Sinkovec M (2012) Low rate of atrial fibrillation recurrence verified by implantable loop recorder monitoring following a convergent epicardial and endocardial ablation of atrial fibrillation. J Cardiovasc Electrophysiol 23:1059–1066CrossRefPubMed
17.
Zuern CS, Kilias A, Berlitz P, Seizer P, Gramlich M, Müller K, Duckheim M, Gawaz M, Schreieck J (2015) Anticoagulation after catheter ablation of atrial fibrillation guided by implantable cardiac monitors. Pacing Clin Electrophysiol 38:688–693CrossRefPubMed
18.
19.
Glotzer TV, Daoud EG, Wyse DG, Singer DE, Ezekowitz MD, Hilker C, Miller C, Qi D, Ziegler PD (2009) The relationship between daily atrial tachyarrhythmia burden from implantable device diagnostics and stroke risk: the TRENDS study. Circ Arrhythm Electrophysiol 2:474–480CrossRefPubMed
20.
Healey JS, Connolly SJ, Gold MR, Israel CW, Van Gelder IC, Capucci A, Lau CP, Fain E, Yang S, Bailleul C, Morillo CA, Carlson M, Themeles E, Kaufman ES, Hohnloser SH, ASSERT Investigators (2012) Subclinical atrial fibrillation and the risk of stroke. N Engl J Med 366:120–129CrossRefPubMed
21.
Ziegler PD, Glotzer TV, Daoud EG, Singer DE, Ezekowitz MD, Hoyt RH, Koehler JL, Coles J Jr, Wyse DG (2012) Detection of previously undiagnosed atrial fibrillation in patients with stroke risk factors and usefulness of continuous monitoring in primary stroke prevention. Am J Cardiol 110:1309–1314CrossRefPubMed
22.
Etgen T, Hochreiter M, Mundel M, Freudenberger T (2013) Insertable cardiac event recorder in detection of atrial fibrillation after cryptogenic stroke: an audit report. Stroke 44:2007–2009CrossRefPubMed
23.
Gladstone DJ, Spring M, Dorian P, Panzov V, Thorpe KE, Hall J, Vaid H, O’Donnell M, Laupacis A, Côté R, Sharma M, Blakely JA, Shuaib A, Hachinski V, Coutts SB, Sahlas DJ, Teal P, Yip S, Spence JD, Buck B, Verreault S, Casaubon LK, Penn A, Selchen D, Jin A, Howse D, Mehdiratta M, Boyle K, Aviv R, Kapral MK, Mamdani M, EMBRACE Investigators and Coordinators (2014) Atrial fibrillation in patients with cryptogenic stroke. N Engl J Med 370:2467–2477CrossRefPubMed
24.
Rem JA, Hachinski VC, Boughner DR, Barnett HJ (1985) Value of cardiac monitoring and echocardiography in TIA and stroke patients. Stroke 16:950–956CrossRefPubMed
25.
Hornig CR, Haberbosch W, Lammers C, Waldecker B, Dorndorf W (1996) Specific cardiological evaluation after focal cerebral ischemia. Acta Neurol Scand 93:297–302CrossRefPubMed
26.
Schuchert A, Behrens G, Meinertz T (1999) Impact of long-term ECG recording on the detection of paroxysmal atrial fibrillation in patients after an acute ischemic stroke. Pacing Clin Electrophysiol 22:1082–1084CrossRefPubMed
27.
Barthelemy JC, Feasson-Gerard S, Garnier P, Gaspoz JM, Da Costa A, Michel D, Roche F (2003) Automatic cardiac event recorders reveal paroxysmal atrial fibrillation after unexplained strokes or transient ischemic attacks. Ann Noninvasive Electrocardiol 8:194–199CrossRefPubMed
28.
Jabaudon D, Sztajzel J, Sievert K, Landis T, Sztajzel R (2004) Usefulness of ambulatory 7‑day ECG monitoring for the detection of atrial fibrillation and flutter after acute stroke and transient ischemic attack. Stroke 35:1647–1651CrossRefPubMed
29.
Schaer BA, Zellweger MJ, Cron TA, Kaiser CA, Osswald S (2004) Value of routine Holter monitoring for the detection of paroxysmal atrial fibrillation in patients with cerebral ischemic events. Stroke 35:e68–e70CrossRefPubMed
30.
Shafqat S, Kelly PJ, Furie KL (2004) Holter monitoring in the diagnosis of stroke mechanism. Intern Med J 34:305–309CrossRefPubMed
31.
Tagawa M, Takeuchi S, Chinushi M, Saeki M, Taniguchi Y, Nakamura Y, Ohno H, Kitazawa K, Aizawa Y (2007) Evaluating patients with acute ischemic stroke with special reference to newly developed atrial fibrillation in cerebral embolism. Pacing Clin Electrophysiol 30:1121–1128CrossRefPubMed
32.
Liao J, Khalid Z, Scallan C, Morillo C, O’Donnell M (2007) Noninvasive cardiac monitoring for detecting paroxysmal atrial fibrillation or flutter after acute ischemic stroke: a systematic review. Stroke 38:2935–2940CrossRefPubMed
33.
Sanna T, Diener HC, Passman RS, Di Lazzaro V, Bernstein RA, Morillo CA, Rymer MM, Thijs V, Rogers T, Beckers F, Lindborg K, Brachmann J, CRYSTAL AF Investigators (2014) Cryptogenic stroke and underlying atrial fibrillation. N Engl J Med 370:2478–2486CrossRefPubMed
34.
Montenero AS, Quayyum A, Franciosa P, Mangiameli D, Antonelli A, Barbieri L, Bruno N, Zumbo F, Vimercati M (2004) Implantable loop recorders: a novel method to judge patient perception of atrial fibrillation. Preliminary results from a pilot study. J Interv Card Electrophysiol 10:211–220CrossRefPubMed
35.
Strickberger SA, Ip J, Saksena S, Curry K, Bahnson TD, Ziegler PD (2005) Relationship between atrial tachyarrhythmias and symptoms. Heart Rhythm 2:125–131CrossRefPubMed
36.
Bloch Thomsen PE, Jons C, Raatikainen MJ, Moerch Joergensen R, Hartikainen J, Virtanen V, Boland J, Anttonen O, Gang UJ, Hoest N, Boersma LV, Platou ES, Becker D, Messier MD, Huikuri HV, Cardiac Arrhythmias and Risk Stratification After Acute Myocardial Infarction (CARISMA) Study Group (2010) Long-term recording of cardiac arrhythmias with an implantable cardiac monitor in patients with reduced ejection fraction after acute myocardial infarction: the Cardiac Arrhythmias and Risk Stratification After Acute Myocardial Infarction (CARISMA) study. Circulation 122:1258–1264CrossRefPubMed
37.
Kapa S, Epstein AE, Callans DJ, Garcia FC, Lin D, Bala R, Riley MP, Hutchinson MD, Gerstenfeld EP, Tzou W, Marchlinski FE, Frankel DS, Cooper JM, Supple G, Deo R, Verdino RJ, Patel VV, Dixit S (2013) Assessing arrhythmia burden after catheter ablation of atrial fibrillation using an implantable loop recorder: the ABACUS study. J Cardiovasc Electrophysiol 24:875–881CrossRefPubMed
38.
Verma A, Champagne J, Sapp J, Essebag V, Novak P, Skanes A, Morillo CA, Khaykin Y, Birnie D (2013) Discerning the incidence of symptomatic and asymptomatic episodes of atrial fibrillation before and after catheter ablation (DISCERN AF): a prospective, multicenter study. JAMA Intern Med 173:149–156CrossRefPubMed
39.
Bax JJ, Delgado V, Bapat V, Baumgartner H, Collet JP, Erbel R, Hamm C, Kappetein AP, Leipsic J, Leon MB, MacCarthy P, Piazza N, Pibarot P, Roberts WC, Rodés-Cabau J, Serruys PW, Thomas M, Vahanian A, Webb J, Zamorano JL, Windecker S (2014) Open issues in transcatheter aortic valve implantation. Part 2: procedural issues and outcomes after transcatheter aortic valve implantation. Eur Heart J 35:2639–2654CrossRefPubMed
40.
Siontis GC, Jüni P, Pilgrim T, Stortecky S, Büllesfeld L, Meier B, Wenaweser P, Windecker S (2014) Predictors of permanent pacemaker implantation in patients with severe aortic stenosis undergoing TAVR: a meta-analysis. J Am Coll Cardiol 64:129–140CrossRefPubMed
41.
Ensminger S, Loders S, Beckendorf C, Feyrer R, Ludwig J, Achenbach S, Weyand M, Arnold M (2013) Continuous rhythm monitoring after Transcatheter Aortic Valve Implantation using an implantable loop recorder. Thorac Cardiovasc Surg 61(S01). doi:10.​1055/​s-0032-1332418
42.
Schymik G, Würth A, Bramlage P, Herbinger T, Heimeshoff M, Pilz L, Schymik JS, Wondraschek R, Süselbeck T, Gerhardus J, Luik A, Gonska BD, Posival H, Schmitt C, Schröfel H (2015) Long-term results of transapical versus transfemoral TAVI in a real world population of 1000 patients with severe symptomatic aortic stenosis. Circ Cardiovasc Interv 8:e000761CrossRefPubMed
43.
Urena M, Rodés-Cabau J (2015) Managing heart block after transcatheter aortic valve implantation: from monitoring to device selection and pacemaker indications. EuroIntervention 11(Suppl W):W101–W105CrossRefPubMed
44.
Athappan G, Gajulapalli RD, Tuzcu ME, Svensson LG, Kapadia SR (2016) A systematic review on the safety of second-generation transcatheter aortic valves. EuroIntervention 11:1034–1043CrossRefPubMed
45.
Biancari F, Rosato S, D’Errigo P, Ranucci M, Onorati F, Barbanti M, Santini F, Tamburino C, Santoro G, Grossi C, Covello RD, Ventura M, Fusco D, Seccareccia F, OBSERVANT Research Group (2016) Immediate and intermediate outcome after transapical versus transfemoral transcatheter aortic valve replacement. Am J Cardiol 117:245–251CrossRefPubMed
46.
Massoullié G, Bordachar P, Ellenbogen KA, Souteyrand G, Jean F, Combaret N, Vorilhon C, Clerfond G, Farhat M, Ritter P, Citron B, Lusson JR, Motreff P, Ploux S, Eschalier R (2016) New-onset left bundle branch block induced by transcutaneous aortic valve implantation. Am J Cardiol 117:867–873CrossRefPubMed
47.
Schernthaner C, Kraus J, Danmayr F, Hammerer M, Schneider J, Hoppe UC, Strohmer B (2016) Short-term pacemaker dependency after transcatheter aortic valve implantation. Wien Klin Wochenschr 128:198–203CrossRefPubMed
48.
Kuck KH, Bordachar P, Borggrefe M, Boriani G, Burri H, Leyva F, Schauerte P, Theuns D, Thibault B, Kirchhof P, Hasenfuss G, Dickstein K, Leclercq C, Linde C, Tavazzi L, Ruschitzka F (2014) New devices in heart failure: an European Heart Rhythm Association report: developed by the European Heart Rhythm Association; endorsed by the Heart Failure Association. Europace 16:109–128CrossRefPubMed
49.
Ahmad K (2009) The role of the ICD in the prevention of sudden death. Cardiol Rounds 13:10
50.
Brignole M, Auricchio A, Baron-Esquivias G, Bordachar P, Boriani G, Breithardt OA, Cleland J, Deharo JC, Delgado V, Elliott PM, Gorenek B, Israel CW, Leclercq C, Linde C, Mont L, Padeletti L, Sutton R, Vardas PE (2013) 2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy. Eur Heart J 34:2281–2329CrossRefPubMed
51.
Bennett T, Kjellstrom B, Taepke R, Ryden L (2005) Development of implantable devices for continuous ambulatory monitoring of central hemodynamic values in heart failure patients. Pacing Clin Electrophysiol 28:573–584CrossRefPubMed
Metadaten
Titel
Current rare indications and future directions for implantable loop recorders
verfasst von
Simon Wechselberger
PD Dr. med. habil. Christopher Piorkowski
Dr. med. Matthias Pohl
Publikationsdatum
21.11.2016
Verlag
Springer Medizin
Erschienen in
Herzschrittmachertherapie + Elektrophysiologie / Ausgabe 4/2016
Print ISSN: 0938-7412
Elektronische ISSN: 1435-1544
DOI
https://doi.org/10.1007/s00399-016-0475-x

Weitere Artikel der Ausgabe 4/2016

Herzschrittmachertherapie + Elektrophysiologie 4/2016 Zur Ausgabe

Schwerpunkt

Implantierbare Sensoren zur ambulanten Beurteilung des ventrikulären Füllungsdrucks bei fortgeschrittener Herzinsuffizienz

Editorial

Kardiovaskuläre diagnostische Implantate: Implantierbarer Loop-Recorder/pulmonal-arterieller Drucksensor

Schwerpunkt

Eventrekorder bei kryptogenem Schlaganfall

Elektrophysiologische Weiterbildung für Kardiologen

AV-Reentry-Tachykardie und Wolff-Parkinson-White-Syndrom

Hugo-von-Ziemssen-Posterpreis

Hugo-von-Ziemssen-Posterpreis

Erratum

Erratum to: Tachycardia detection in modern implantable cardioverter–defibrillators

Neu im Fachgebiet Kardiologie

23.04.2024 | Ablationstherapie | Nachrichten

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

23.04.2024 | Prävention und Rehabilitation in der Kardiologie | Nachrichten

Europäische Ernährungsgewohnheiten: Das sind die häufigsten Fehler

19.04.2024 | Vorhofflimmern | Nachrichten

Parodontalbehandlung verbessert Prognose bei Katheterablation

18.04.2024 | Arterielle Hypertonie | Nachrichten

Antihypertensiva schützen auch alte Menschen noch vor Demenz
weitere anzeigen

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen